Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-6901
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2 ; day:5 ; month:8 ; year:2021 ; pages:1-4
Drugs in R & D ; (5.8.2021), 1-4
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40268-021-00358-z
- URN
-
urn:nbn:de:101:1-2021103010510161985969
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sprute, Rosanne
- Schumacher, Sofie
- Pauls, Martina
- Pauls, Wolfgang
- Cornely, Oliver Andreas
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cutaneous Metal Hypersensitivity Reaction
Cysteine-type cathepsins promote the effector phase of acute cutaneous delayed-type hypersensitivity reactions
Acute and chronic inflammation alter immunometabolism in a cutaneous delayed-type hypersensitivity reaction (DTHR) mouse model
Management of suspected and confirmed COVID‐19 (SARS‐CoV‐2) vaccine hypersensitivity
Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity
Management of suspected and confirmed COVID‐19 (SARS‐CoV‐2) vaccine hypersensitivity
Cutaneous hypersensitivity reactions to freshwater cyanobacteria – human volunteer studies
Multiple drug hypersensitivity associated with severe cutaneous adverse reaction
An unexpected role of decorin in delayed-type hypersensitivity
Involvement of the activating receptor NKG2D in cutaneous hypersensitivity drug reactions
Is cancer a severe delayed hypersensitivity reaction and histamine a blueprint?
Immunomodulatory role of reactive oxygen species and nitrogen species during T cell-driven neutrophil-enriched acute and chronic cutaneous delayed-type hypersensitivity reactions
Cutaneous Metal Hypersensitivity Reaction
Cysteine-type cathepsins promote the effector phase of acute cutaneous delayed-type hypersensitivity reactions
Acute and chronic inflammation alter immunometabolism in a cutaneous delayed-type hypersensitivity reaction (DTHR) mouse model
Management of suspected and confirmed COVID‐19 (SARS‐CoV‐2) vaccine hypersensitivity
Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity
Management of suspected and confirmed COVID‐19 (SARS‐CoV‐2) vaccine hypersensitivity
Cutaneous hypersensitivity reactions to freshwater cyanobacteria – human volunteer studies
Multiple drug hypersensitivity associated with severe cutaneous adverse reaction
An unexpected role of decorin in delayed-type hypersensitivity
Involvement of the activating receptor NKG2D in cutaneous hypersensitivity drug reactions
Is cancer a severe delayed hypersensitivity reaction and histamine a blueprint?
Immunomodulatory role of reactive oxygen species and nitrogen species during T cell-driven neutrophil-enriched acute and chronic cutaneous delayed-type hypersensitivity reactions
Cutaneous Metal Hypersensitivity Reaction
Cysteine-type cathepsins promote the effector phase of acute cutaneous delayed-type hypersensitivity reactions
Acute and chronic inflammation alter immunometabolism in a cutaneous delayed-type hypersensitivity reaction (DTHR) mouse model
Management of suspected and confirmed COVID‐19 (SARS‐CoV‐2) vaccine hypersensitivity
Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity
Management of suspected and confirmed COVID‐19 (SARS‐CoV‐2) vaccine hypersensitivity
Cutaneous hypersensitivity reactions to freshwater cyanobacteria – human volunteer studies
Multiple drug hypersensitivity associated with severe cutaneous adverse reaction
An unexpected role of decorin in delayed-type hypersensitivity
Involvement of the activating receptor NKG2D in cutaneous hypersensitivity drug reactions
Is cancer a severe delayed hypersensitivity reaction and histamine a blueprint?